Efficacy of Calmmax Cream in the Management of Chronic Uremic Pruritus
Last updated on April 2022Recruitment
- Recruitment Status
- Unknown status
Inclusion Criteria
- Discontinuation of any medication with presumed antipruritic effects at least 1 week before the study (including Calmmax cream)
- History of pruritus of >8 weeks duration.
- Severity score of pruritus ≥5 as defined by VAS
- ...
- Discontinuation of any medication with presumed antipruritic effects at least 1 week before the study (including Calmmax cream)
- History of pruritus of >8 weeks duration.
- Severity score of pruritus ≥5 as defined by VAS
- Negative pregnancy test result for all participating women of childbearing age;
Exclusion Criteria
- Known poor adherence to medical recommendations
- Any acute illness
- Liver cirrhosis
- ...
- Known poor adherence to medical recommendations
- Any acute illness
- Liver cirrhosis
- Known allergy to Calmmax cream
- Inability to give informed consent
- Active dermatological disorder other than UP
- Decompensated heart failure
Summary
- Conditions
- Calmmax Cream on UP in CKD Patients.
- Type
- Interventional
- Design
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Inclusion Criteria
- Discontinuation of any medication with presumed antipruritic effects at least 1 week before the study (including Calmmax cream)
- History of pruritus of >8 weeks duration.
- Severity score of pruritus ≥5 as defined by VAS
- ...
- Discontinuation of any medication with presumed antipruritic effects at least 1 week before the study (including Calmmax cream)
- History of pruritus of >8 weeks duration.
- Severity score of pruritus ≥5 as defined by VAS
- Negative pregnancy test result for all participating women of childbearing age;
Exclusion Criteria
- Known poor adherence to medical recommendations
- Any acute illness
- Liver cirrhosis
- ...
- Known poor adherence to medical recommendations
- Any acute illness
- Liver cirrhosis
- Known allergy to Calmmax cream
- Inability to give informed consent
- Active dermatological disorder other than UP
- Decompensated heart failure
Tracking Information
- NCT #
- NCT02032537
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Itzchak Slotki, MD Shaare Zedek Medical Center
- Itzchak Slotki, MD Shaare Zedek Medical Center
Get Well Soon